Search

everythinglearnresearchcommunity

for

Search:↓

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Topical finasteride promotes hair growth with minimal side effects but needs more research for women and optimal use.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

Chitosan microparticles improve minoxidil sulphate delivery, potentially reducing daily applications.

Laser laparoscopy effectively reduces pelvic pain in women with mild to moderate endometriosis and is safe to use.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

A spermidine-based supplement may help hair grow longer by keeping it in the growth phase.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

The Naked (N) trait in mice is linked to lower glycine and tyrosine in hair proteins.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

Researchers found 19 genes important for root hair growth in a plant called Arabidopsis.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Polyamines help fix DNA damage accurately in cells.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.